Astragalus polysaccharide antagonized anti PD-1 efficacy in melanoma through inhibiting JAK-STAT1/CIITA and TLR/NF-κB signaling
Ruilong Wang, Qiao Li, Mengguo Liu, Jinshu Yu, Min Peng, Xiaohong Deng, Rui Lei, Xiao Liu, Zhihao Li, Hiochon Leong, Jie Ren, Jinfeng Wu · 2026
Read Astragalus polysaccharide antagonized anti PD-1 efficacy in melanoma through inhibiting JAK-STAT1/CIITA and TLR/NF-κB signaling by Ruilong Wang, Qiao Li, Mengguo Liu, Jinshu Yu, Min Peng, Xiaohong Deng, Rui Lei, Xiao Liu, Zhihao Li, Hiochon Leong, Jie Ren, Jinfeng Wu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13616731.txt.
Description
A plant extract sold as an immune booster might weaken a top melanoma drug instead of helping it. Ruilong Wang and co-authors found that clash in a 2026 mouse study. The extract, from the astragalus plant, is approved in China as a cancer aid. The drug it was paired with frees the immune system to attack tumors. Mice with melanoma got both treatments together.
The extract sharply cut the drug's tumor-fighting effect. Killer immune cells entered the tumors in smaller numbers, and helper cells woke up less. Two signal paths that tumors need for immune visibility were damped by the extract. A master switch for showing tumor flags to immune cells was turned down. The authors warn that booster pairings need testing, not trust.
Catalog record
| CREATOR | Ruilong Wang, Qiao Li, Mengguo Liu, Jinshu Yu, Min Peng, Xiaohong Deng, Rui Lei, Xiao Liu, Zhihao Li, Hiochon Leong, Jie Ren, Jinfeng Wu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 33 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |